BMC Geriatrics,
Journal Year:
2024,
Volume and Issue:
24(1)
Published: Oct. 30, 2024
Sarcopenia
has
been
shown
to
be
an
important
condition
with
the
ability
predict
negative
health
outcomes,
especially
in
hospitalized
older
adults;
hence,
its
accurate
identification
role
prognosis
of
patients.
Pharmacological Reviews,
Journal Year:
2024,
Volume and Issue:
76(3), P. 454 - 499
Published: Jan. 30, 2024
Steatotic
liver
disease
(SLD)
displays
a
dynamic
and
complex
phenotype.
Consequently,
the
metabolic
dysfunction-associated
steatotic
(MASLD)/metabolic
steatohepatitis
(MASH)
therapeutic
pipeline
is
expanding
rapidly
in
multiple
directions.
In
parallel,
non-invasive
tools
for
diagnosing
monitoring
responses
to
interventions
are
being
studied,
clinically
feasible
findings
explored
as
primary
outcomes
interventional
trials.
The
realization
that
distinct
subgroups
exist
under
umbrella
of
SLD
should
guide
more
precise
personalized
treatment
recommendations
facilitate
advancements
pharmacotherapeutics.
This
review
summarizes
recent
updates
pathophysiology-based
nomenclature
outlines
both
effective
pharmacotherapeutics
those
MASLD/MASH,
detailing
their
mode
action
current
status
phase
2
3
clinical
Of
extensive
arsenal
MASLD/MASH
pipeline,
several
have
been
rejected,
whereas
other,
mainly
monotherapy
options,
shown
only
marginal
benefits
now
tested
part
combination
therapies,
yet
others
still
development
monotherapies.
Although
successful
drug
candidate
(or
combinations)
remains
elusive,
such
approaches
will
ideally
target
MASH
fibrosis
while
improving
cardiometabolic
risk
factors.
Due
urgent
need
novel
strategies
potential
availability
safety
tolerability
data,
repurposing
existing
approved
drugs
an
appealing
option.
Finally,
it
essential
highlight
and,
by
extension,
MASLD
be
recognized
approached
systemic
affecting
organs,
with
vigorous
implementation
interdisciplinary
coordinated
plans.
Significance
Statement
SLD,
including,
among
others,
MASH,
considered
most
prevalent
chronic
condition
than
one-fourth
global
population.
aims
provide
information
regarding
pathophysiology,
diagnosis,
management
line
guidelines
Collectively,
hoped
provided
furthers
understanding
state
direct
implications
stimulates
additional
research
initiatives.
The
triad
of
vascular
impairment,
muscle
atrophy,
and
cognitive
decline
represents
critical
age-related
conditions
that
significantly
impact
health.
Vascular
impairment
disrupts
blood
flow,
precipitating
mass
reduction
seen
in
sarcopenia
the
neuronal
functions
characteristic
neurodegeneration.
Our
limited
understanding
intricate
relationships
within
this
hinders
accurate
diagnosis
effective
treatment
strategies.
This
review
ana-lyzes
interrelated
mechanisms
contribute
to
these
conditions,
with
a
specific
focus
on
ox-idative
stress,
chronic
inflammation,
impaired
nutrient
delivery.
aim
is
understand
common
pathways
involved
suggest
comprehensive
therapeutic
approaches.
dysfunctions
hinder
circulation
transportation
nutrients,
resulting
sar-copenia
characterized
by
atrophy
weakness.
dysfunction
have
negative
physical
function
quality
life.
Neurodegenerative
diseases
exhibit
comparable
pathophysiological
affect
motor
functions.
Preventive
approaches
encompass
lifestyle
adjustments,
addressing
oxidative
in-flammation,
integrated
therapies
improving
muscular
well-being.
Better
links
can
refine
strategies
yield
better
patient
out-comes.
study
emphasizes
complex
interplay
between
dysfunction,
de-generation,
decline,
highlighting
necessity
for
multidisciplinary
ap-proaches.
Advances
domain
promise
improved
diagnostic
accuracy,
more
thera-peutic
options,
enhanced
preventive
measures,
all
contributing
higher
life
elderly
population.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(3), P. e0320079 - e0320079
Published: March 19, 2025
Physical
functioning
refers
to
the
ability
perform
daily
living
activities,
namely
basic
instrumental,
and
advanced
activities.
Poorer
performance
in
these
areas
may
indicate
potential
presence
of
sarcopenia.
To
analyze
differences
physical
function
between
older
people
with
without
sarcopenia
investigate
associations
tests
A
cross-sectional
study
based
on
data
from
Northern
region
Brazil
year
2018
was
conducted.
Study
participants
included
312
aged
≥
60
years
(64.1%
female).
Sarcopenia
defined
using
updated
criteria
European
Working
Group
Older
People
(EWGSOP2).
measured
functional
fitness
(30-second
chair
stand
test,
sit-and-reach
8-foot
Up-and-Go
Test,
6-minute
walk
4-meter
gait
speed,
Fullerton
Advanced
Balance
Scale).
Confirmed
detected
29.2%
participants,
but
no
participant
had
severe
Most
parameters
crude
analysis
were
associated
confirmed
(all
p
<
0.05),
except
for
back
scratch
test.
In
a
model
adjusted
sex,
age
body
mass
index,
slower
speed
(OR
=
1.29,
95%CI
1.08
1.54),
up-and-go
test
time
1.32,
1.16
1.49),
greater
0.97,
0.94
0.99)
higher
self-reported
Composite
Function
scores
0.94,
0.89
significantly
status.
EWGSOP2
is
prevalent
residing
Brazil's
independently
walking
rising
ability,
reduced
trunk
lower-limb
flexibility,
as
well
poorer
function.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(9), P. 2096 - 2096
Published: Sept. 13, 2024
The
triad
of
vascular
impairment,
muscle
atrophy,
and
cognitive
decline
represents
critical
age-related
conditions
that
significantly
impact
health.
Vascular
impairment
disrupts
blood
flow,
precipitating
the
mass
reduction
seen
in
sarcopenia
neuronal
function
characteristic
neurodegeneration.
Our
limited
understanding
intricate
relationships
within
this
hinders
accurate
diagnosis
effective
treatment
strategies.
This
review
analyzes
interrelated
mechanisms
contribute
to
these
conditions,
with
a
specific
focus
on
oxidative
stress,
chronic
inflammation,
impaired
nutrient
delivery.
aim
is
understand
common
pathways
involved
suggest
comprehensive
therapeutic
approaches.
dysfunctions
hinder
circulation
transportation
nutrients,
resulting
characterized
by
atrophy
weakness.
dysfunction
have
negative
physical
quality
life.
Neurodegenerative
diseases
exhibit
comparable
pathophysiological
affect
motor
functions.
Preventive
approaches
encompass
lifestyle
adjustments,
addressing
integrated
therapies
improving
muscular
well-being.
Better
links
can
refine
strategies
yield
better
patient
outcomes.
study
emphasizes
complex
interplay
between
dysfunction,
degeneration,
decline,
highlighting
necessity
for
multidisciplinary
Advances
domain
promise
improved
diagnostic
accuracy,
more
options,
enhanced
preventive
measures,
all
contributing
higher
life
elderly
population.
The journal of nutrition health & aging,
Journal Year:
2024,
Volume and Issue:
28(8), P. 100290 - 100290
Published: June 21, 2024
An
age-dependent
normative
values
of
calf
circumference
(CC)
has
been
recently
proposed
as
an
accessible
proxy
for
muscle
mass.
However,
its
usefulness
to
estimate
sarcopenia
not
assessed.
The
objectives
the
present
study
were
determine
if
substitution
classical
way
assess
mass
by
these
have
enough
diagnostic
accuracy
and
prognostic
value
among
older
adults
living
in
community.
Current Opinion in Clinical Nutrition & Metabolic Care,
Journal Year:
2024,
Volume and Issue:
27(5), P. 402 - 409
Published: July 18, 2024
Sarcopenic
obesity
is
a
likely
common,
but
certainly
underestimated
phenotype,
with
an
important
negative
clinical
impact.
Its
definition
and
diagnosis
have
however
remained
elusive
until
recently.